1402555-42-3

Basic information

• Product Name: 2-[2-fluoro-4-(2-{(1S,2R)-2-[1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]cyclopropyl}ethoxy)phenyl]acetohydrazide
• Synonyms: 2-[2-fluoro-4-(2-{(1S,2R)-2-[1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]cyclopropyl}ethoxy)phenyl]acetohydrazide
• CAS NO: 1402555-42-3
• Molecular Weight: 445.537
• Mol File: 1402555-42-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-[2-fluoro-4-(2-{(1S,2R)-2-[1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]cyclopropyl}ethoxy)phenyl]acetohydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-fluoro-4-(2-{(1S,2R)-2-[1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]cyclopropyl}ethoxy)phenyl]acetohydrazide(1402555-42-3)
• EPA Substance Registry System: 2-[2-fluoro-4-(2-{(1S,2R)-2-[1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]cyclopropyl}ethoxy)phenyl]acetohydrazide(1402555-42-3)

Safety Data

• Hazardous Substances Data: 1402555-42-3(Hazardous Substances Data)

Upstream product

• 287192-97-6 4-ethynyl-piperidine-1-carboxylic acid tert-butyl ester 
• 68886-07-7 (2-fluoro-4-hydroxylphenyl)acetic acid 
• 91361-59-0 methyl 2-(2-fluoro-4-hydroxyphenyl)acetate 
• 1192063-78-7 tert-butyl 4-[(4R)-5-(benzyloxy)-4-hydroxypent-1-yn-1-yl]piperidine-1-carboxylate 
• 1402555-23-0 methyl[2-fluoro-4-(2-{(1S,2R)-[1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]cyclopropyl}ethoxy)phenyl]acetate 
• 1402555-24-1 2-fluoro-4-(2-{(1S,2R)-[1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]cyclopropyl}ethoxy)phenyl acetic acid 
• 1402554-86-2 4-((1R,2S)-2-(2-hydroxyethyl)cyclopropyl)piperidine-1-carbonitrile 
• 1402554-67-9 benzyl 4-[(1R,2S)-2-(2-hydroxyethyl)cyclopropyl]piperidine-1-carboxylate 
• 1402554-66-8 benzyl 4-[-2-(2-hydroxyethyl)cyclopropyl]piperidine-1-carboxylate 

Downstream Products

• 1402554-44-2 C₂₄H₃₀FN₅O₃ 

Relevant articles and documents

SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

Substituted cyclopropyl compounds of the formula I: and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR-119. Pharmaceutical compositions and methods of treatment are also included